news

16/09/2025

SPEEDCELL, the new European project led by HIPRA, aims to reduce vaccine and biologics development to 100 days in emergency situations

Nota de prensa (PDF)

Share

LinkedIn
Facebook
X
Email

Suscribe to our newsletter

for all the latest news

Accelerate the development 
and production of biologics

Linkedin

Copyright © 2025, Speedcell . All rights reserved.

 Cookies policy     Privacy Policy

Cofunded by the European Union under grant agreement No 101136439. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union (EU) or European Health and Digital Executive Agency (HaDEA). Neither the EU nor HaDEA can be held responsible for them.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.